Jerry M. Collins

12.1k citations

176 papers · 9.0k indexed · h-index 52

Impact in

Oncology top 0.5%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- Colorectal Cancer Treatments and Studies
Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism

Papers in

Pharmacology 24
- Pharmacogenetics and Drug Metabolism 23
Oncology 64
- Cancer Treatment and Pharmacology 28
- Colorectal Cancer Treatments and Studies 14

Co-authors: Charles E. Myers Raymond W. Klecker James H. Doroshow Robert L. Dedrick James L. Speyer David G. Poplack Larry Rubinstein Susan L. Holbeck
Journals: Journal of Clinical Oncology (16 papers)Clinical Pharmacology & Therapeutics (13 papers)Cancer Chemotherapy and Pharmacology (13 papers)Cancer Research (12 papers)The Journal of Clinical Pharmacology (7 papers)
Partner nations: United States Malaysia Ukraine

In The Last Decade

Jerry M. Collins

167 papers receiving 8.6k citations

Peers

Countries citing papers authored by Jerry M. Collins

Since Specialization

Citations

This map shows the geographic impact of Jerry M. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry M. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry M. Collins more than expected).

Fields of papers citing papers by Jerry M. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry M. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry M. Collins. The network helps show where Jerry M. Collins may publish in the future.

Co-authors

The 25 scholars most cited alongside Jerry M. Collins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jerry M. Collins Line = papers co-authored together Jerry M. Collins links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd Molecular Cancer Therapeutics ·Joel Morris, Donn G. Wishka, Omar D. Lopez, V. F. Rudchenko, Guangfei Huang, Sierra N. Hoffman, Suzanne Borgel, Kyle Georgius, John Carter, Howard Stotler, Mark W. Kunkel, Jerry M. Collins, Melinda G. Hollingshead, Beverly A. Teicher	2021	7
2	Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation Clinical Cancer Research ·Timothy J. Kinsella, Howard Safran, Susan R. Wiersma, Thomas A. DiPetrillo, Andrew Schumacher, Kayla Rosati, John Vatkevich, Lawrence W. Anderson, Kimberly D. Hill, Charles A. Kunos, Jerry M. Collins	2019	4
3	Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas Molecular Cancer Therapeutics ·Long‐Sheng Chang, Janet L. Oblinger, Sarah S. Burns, Jie Huang, Larry W. Anderson, Melinda G. Hollingshead, Rulong Shen, Pan Li, Garima Agarwal, Yulin Ren, Ryan D. Roberts, Barry R. O’Keefe, A. Douglas Kinghorn, Jerry M. Collins	2019	16
4	Erythrofordins D and E, two new cassaine-type diterpenes from Erythrophleum suaveolens Bioorganic & Medicinal Chemistry Letters ·Tanja Grkovic, Jason R. Evans, Rhone K. Akee, Liang Guo, Mark M. Davis, Johnson Jato, Paul G. Grothaus, Michelle Ahalt-Gottholm, Melinda G. Hollingshead, Jerry M. Collins, David Newman, Barry R. O’Keefe	2018	8
5	The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity Cancer Research ·Susan L. Holbeck, Richard F. Camalier, James A. Crowell, Jeevan Prasaad Govindharajulu, Melinda G. Hollingshead, Lawrence W. Anderson, Eric C. Polley, Larry Rubinstein, Apurva K. Srivastava, Deborah Wilsker, Jerry M. Collins, James H. Doroshow	2017	214
6	Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors Journal of Clinical Oncology ·T. Khanh, Deborah Wilsker, Jiuping Ji, Jennifer Zlott, Tomoko Freshwater, Robert J. Kinders, Jerry M. Collins, Alice P. Chen, James H. Doroshow, Shivaani Kummar	2015	255
7	Phase I study of the synthetic triterpenoid, 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid (CDDO), in advanced solid tumors Cancer Chemotherapy and Pharmacology ·Giovanna Speranza, Martin Gutierrez, Shivaani Kummar, John M. Strong, Robert Parker, Jerry M. Collins, Yunkai Yu, Liang Cao, Anthony J. Murgo, James H. Doroshow, Alice P. Chen	2011	23
8	Analysis of Food and Drug Administration–Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines Molecular Cancer Therapeutics ·Susan L. Holbeck, Jerry M. Collins, James H. Doroshow	2010	239
9	Compressing drug development timelines in oncology using phase '0' trials Nature reviews. Cancer ·Shivaani Kummar, Robert J. Kinders, Larry Rubinstein, Ralph E. Parchment, Anthony J. Murgo, Jerry M. Collins, Oxana K. Pickeral, Jennifer A. Low, Seth M. Steinberg, Martin Gutierrez, Sherry X. Yang, Lee J. Helman, Robert H. Wiltrout, Joseph E. Tomaszewski, James H. Doroshow	2007	145
10	Review of microdialysis in brain tumors, from concept to application:First Annual Carolyn Frye-Halloran Symposium Neuro-Oncology ·Ramsis Benjamin, Fred H. Hochberg, Elizabeth Fox, Peter M. Bungay, William F. Elmquist, Clinton F. Stewart, James M. Gallo, Jerry M. Collins, Robert P. Pelletier, John de Groot, Robert C. Hickner, Idil Çavuş, Stuart A. Grossman, O. Michael Colvin	2004	40
11	Metabolism by N‐Acetyltransferase 1 In Vitro and in Healthy Volunteers: A Prototype for Targeted Inhibition The Journal of Clinical Pharmacology ·Louis R. Cantilena, Aspandiar G. Katki, Raymond W. Klecker, Jerry M. Collins	2004	2
12	Idiosyncratic drug toxicity Chemico-Biological Interactions ·Jerry M. Collins	2002	3
13	Thymidine phosphorylase as a target for imaging and therapy with thymine analogs Cancer Chemotherapy and Pharmacology ·Raymond W. Klecker, Jerry M. Collins	2001	8
14	Inter-species differences in drug properties Chemico-Biological Interactions ·Jerry M. Collins	2001	33
15	Thalidomide pharmacokinetics do not change with chronic administration Clinical Pharmacology & Therapeutics ·Stephen Donahue, Jerry M. Collins, D. A. Flockhart, D. R. Abernethy, Carol Braun Trapnell	1997	3
16	Similarity of metabolism for CAI (NSC 609974) in human liver tissue in vitro and in humans in vivo PubMed ·Linda K Ludden, John M. Strong, Elise C. Kohn, Jerry M. Collins	1995	11
17	Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer Cancer Chemotherapy and Pharmacology ·Carlos Jamis‐Dow, Raymond W. Klecker, Gisele Sarosy, Eddie Reed, Jerry M. Collins	1993	60
18	Opportunities for Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development Journal of Pharmaceutical Sciences ·Carl C. Peck, William H. Barr, Leslie Z. Benet, Jerry M. Collins, Robert E. Desjardins, Daniel E. Furst, John G. Harter, Gerhard Levy, Thomas M. Ludden, John H. Rodman, Lilly Sanathanan, Jerome J. Schentag, Vinod P. Shah, Lewis B. Sheiner, Jerome P. Skelly, Donald R. Stanski, Robert J. Temple, C.T. Viswanathan, Judi Weissinger, Avraham Yacobi	1992	49
19	Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. Journal of Clinical Oncology ·Timothy J. Kinsella, Jerry M. Collins, J. Mark Rowland, R W Klecker, Donald Wright, David A. Katz, Seth M. Steinberg, E Glastein	1988	83
20	The murine disposition and pharmacokinetics of the antineoplastic agent, diaziquone (NSC 182986). Drug Metabolism and Disposition ·JL. Spiegel, Merrill J. Egorin, Jerry M. Collins, Betiana Lerner, N R Bachur	1983	3

About Jerry M. Collins

Jerry M. Collins is a scholar working on Pharmacology, Oncology, Genetics, Statistics and Probability and Cancer Research, having authored 176 papers that have together received 9.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (28 papers), Pharmacogenetics and Drug Metabolism (23 papers), Cancer therapeutics and mechanisms (17 papers), Glioma Diagnosis and Treatment (15 papers), Colorectal Cancer Treatments and Studies (14 papers), HIV/AIDS drug development and treatment (13 papers), Lung Cancer Treatments and Mutations (13 papers) and Statistical Methods in Clinical Trials (12 papers). The work is most often cited by research in Oncology (3.1k citations), Pharmacology (989 citations), Virology (414 citations), Genetics (740 citations) and Statistics and Probability (510 citations). Jerry M. Collins has collaborated with scholars based in United States, Malaysia and Ukraine. Frequent co-authors include Charles E. Myers, Raymond W. Klecker, James H. Doroshow, Robert L. Dedrick, James L. Speyer, David G. Poplack, Larry Rubinstein, Susan L. Holbeck, Jean Jenkins and Bruce A. Chabner. Their work appears in journals such as Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics, Cancer Chemotherapy and Pharmacology, Cancer Research and The Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact